US$ 21.87
ghk-cu plasma levels age 60 7% ACCELERANT GHK-Cu for Skin & Wound
Description
Works well for most adults with average to above-average subcutaneous fat

En el estudio intravenoso humano de pequeo tamao (n=6), el DSIP se report como bien tolerado , sin efectos adversos psicolgicos, fisiolgicos ni bioqumicos observados (PMID 6895513)

Advanced formulation designed for metabolic optimization and performance

selection depends on peptide solubility and downstream assay requirements

J., Abhijit K., Rosalba P
